Medicament for treating nerve dysfunction after refraining opium type material
A neurological function and opioid technology, applied in the fields of addiction medicine and neurobiology, can solve the problems of restricting the use of traditional Chinese medicine preparations and unclear toxic effects of traditional Chinese medicine, so as to help the body recover, shorten the withdrawal time, and relieve neurological function Effects of Disorder Symptoms
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2010-08-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical fields of addiction medicine and neurobiology, in particular to a medicine for treating neurological dysfunction after opioid withdrawal. technical background
[0002] Dependent behavior is a series of cognitive, behavioral, and physiological symptoms produced by addictive substances acting on the susceptible brain. Although the user is very aware of the obvious problems caused by the use of dependent substances, he continues to use them, resulting in Tolerance, dependence symptoms after drug withdrawal and compulsive drug seeking behavior (compulsive drug seeking behavior). Once these symptoms are formed, they persist for a long time. Even after abstinence for several years or even longer, there is still a strong sense of drug craving and the possibility of relapse[1]. Opioids are the most important type of addictive drugs. The use of opioids has brought huge damage to individuals, families, and society, resulti...
Examples
Embodiment 1
[0025] Drug formulation:
[0026] Atropine: baclofen (according to mass ratio)=1: 1 (both atropine and baclofen are commercially available products)
[0027] Preparation:
[0028] The analytically pure medicine is respectively dissolved in physiological saline according to atropine:baclofen (according to the mass ratio)=1:1, and mixed uniformly to obtain the compound preparation of the present invention.
Embodiment 2
[0030] Pharmaceutical formula: atropine: baclofen (according to mass ratio)=1:5
[0031] The preparation method is the same as in Example 1.
Embodiment 3
[0033] Drug formulation:
[0034] Atropine: Baclofen (according to mass ratio)=1:10
[0035] The preparation method is the same as in Example 1.